Navigation Links
UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
Date:6/11/2012

Haydale Limited ("Haydale"), and Cheap Tubes Inc ("CTi"), today announce that they have reached agreement for CTi to act as the exclusive agent for the supply of the Haydale HDPlas nano products in the United States, Canada, and Mexico.

Haydale's unique patented Split Plasma based technology enables the scaleable, environmentally friendly, exfoliation and purification of single and few layer friable Graphenes containing powders known as Graphene Nano Platelets ("GNPs") from mined graphite crystals. Under the agreement Haydale will supply its GNPs and Split Plasma treated Carbon Nano Tubes ("CNTs") which are now available from CTi under the brand HDPlas.

Critically, organisations can now use the HDPlas product range for collaborative product prototyping and analysis. Haydale offers expertise in running pilot trials to evaluate the effect their friable GNPs have on the clients' materials and products and, crucially, assessing their suitability for large scale production. The key to subsequent take up by the client is the knowledge that there is a reliable, quality product available in commercial quantities.

As part of the agreement CTi will be exhibiting the HDPlas products and offering samples to attendees at the TechConnect World NSTI conference in Santa Clara on June 18- 21st.

"TechConnect has always been a fantastic trade show for us to exhibit our products at; please visit us at booth #506 to enquire about our HDPlas products" says CTI's President Mike Foley.

Haydale's Commercial Director Ray Gibbs said:

"The market is looking for ways of using the new wonder material Graphene and we believe that we have the process that can now supply both the research and commercial quantities required. Haydale is now able to supply HDPlas from stock in grams or kilos and is ready and able to take orders for tonnes to agreed delivery dates. CTi offers us a real means of quickly getting our quality products initially into the research community which is a vital part of our route to market strategy.

"Our cutting edge technology has been peer reviewed and we can now do "what it says on the tin". We have proven that we can personalise solutions to a client's specific needs in a cost effective, environmentally friendly and innovative way. Getting this right enables materials like our Graphenes to be effectively exploited and Haydales' technical capability coupled with the CTi sales breadth equips us both to meet these challenges"

Commenting on the agreement, CTi's President Mike Foley said:

"The agency agreement formalises a business relationship that has been ongoing for some time. There are a lot of synergies between our respective companies and our shared business philosophy of striving to act with integrity in everything we do will enable us to build our respective businesses on the foundation we already have in place.

The Haydale offerings have already been well received by our customer base and the breadth of innovative products they offer was critical in convincing us that we should take on the exclusive agency. The quality and competitive pricing for their GNPs and CNTs is a major enhancement to our range of materials that our clients can now access. I am confident that anyone trying a research quantity will want some more material once they have evaluated the HDPlas products. The real attraction is that the surface functionalities can be tailored to meet the requirements of our clients. In addition, the fact that Haydale can quickly supply more than kilos at the same high quality is a real plus for those looking to move into development phase and commercialise their product. We are delighted to formally add these top quality products to our product lines and I expect business to be brisk at the forthcoming TechConnect Conference."


'/>"/>
Contact: Trevor Phillips
trevor.phillips@hermesfinancialpr.co.uk
44-788-915-3628
Hermes Financial Public Relations
Source:Eurekalert  

Related biology technology :

1. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
2. TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
3. Sequenom Announces Participation at the Jefferies Global Healthcare Conference
4. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
5. EPSRC announces first recipients of Fellowships in Manufacturing
6. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
7. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
8. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
9. Diversionary Therapy Announces First Sale of ditto™ dental
10. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
11. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Calif. , June 23, 2016  The Prostate Cancer Foundation ... increasingly precise treatments and faster cures for prostate cancer. Members of the Class ... across 15 countries. Read More About the Class of ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
Breaking Biology Technology:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
Breaking Biology News(10 mins):